These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9374372)

  • 1. Deletion mapping on chromosome 17p in medulloblastoma.
    Steichen-Gersdorf E; Baumgartner M; Kreczy A; Maier H; Fink FM
    Br J Cancer; 1997; 76(10):1284-7. PubMed ID: 9374372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of chromosome 17p loss with clinical outcome in medulloblastoma.
    Emadian SM; McDonald JD; Gerken SC; Fults D
    Clin Cancer Res; 1996 Sep; 2(9):1559-64. PubMed ID: 9816333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetic studies in medulloblastomas: evidence for tumor suppressor genes at the chromosomal regions 1q31-32 and 17p13.
    Pietsch T; Koch A; Wiestler OD
    Klin Padiatr; 1997; 209(4):150-5. PubMed ID: 9293446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypermethylation of HIC-1 and 17p allelic loss in medulloblastoma.
    Rood BR; Zhang H; Weitman DM; Cogen PH
    Cancer Res; 2002 Jul; 62(13):3794-7. PubMed ID: 12097291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity at locus F13B on chromosome 1q in human medulloblastoma.
    Kraus JA; Koch A; Albrecht S; Von Deimling A; Wiestler OD; Pietsch T
    Int J Cancer; 1996 Jul; 67(1):11-5. PubMed ID: 8690510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of multiple chromosome 17p loci in medulloblastoma tumorigenesis.
    Cogen PH; Daneshvar L; Metzger AK; Duyk G; Edwards MS; Sheffield VC
    Am J Hum Genet; 1992 Mar; 50(3):584-9. PubMed ID: 1347196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical mapping of chromosome 17p13.3 in the region of a putative tumor suppressor gene important in medulloblastoma.
    McDonald JD; Daneshvar L; Willert JR; Matsumura K; Waldman F; Cogen PH
    Genomics; 1994 Sep; 23(1):229-32. PubMed ID: 7829075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity analysis of chromosome 17p13.1-13.3 and its correlation with clinical outcome in medulloblastomas.
    Jung HL; Wang KC; Kim SK; Sung KW; Koo HH; Shin HY; Ahn HS; Shin HJ; Cho BK
    J Neurooncol; 2004; 67(1-2):41-6. PubMed ID: 15072446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microsatellite analysis of loss of heterozygosity on chromosomes 9q, 11p and 17p in medulloblastomas.
    Albrecht S; von Deimling A; Pietsch T; Giangaspero F; Brandner S; Kleihues P; Wiestler OD
    Neuropathol Appl Neurobiol; 1994 Feb; 20(1):74-81. PubMed ID: 8208343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of the lissencephaly gene 1 (LIS-1) in medulloblastomas.
    Koch A; Tonn J; Kraus JA; Sorensen N; Albrecht NS; Wiestler OD; Pietsch T
    Neuropathol Appl Neurobiol; 1996 Jun; 22(3):233-42. PubMed ID: 8804025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High resolution loss of heterozygosity mapping of 17p13 in thyroid cancer: Hurthle cell carcinomas exhibit a small 411-kilobase common region of allelic imbalance, probably containing a novel tumor suppressor gene.
    Farrand K; Delahunt B; Wang XL; McIver B; Hay ID; Goellner JR; Eberhardt NL; Grebe SK
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4715-21. PubMed ID: 12364463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix.
    Kersemaekers AM; Hermans J; Fleuren GJ; van de Vijver MJ
    Br J Cancer; 1998; 77(2):192-200. PubMed ID: 9460988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelic deletion on chromosome 17p13.3 in early ovarian cancer.
    Phillips NJ; Ziegler MR; Radford DM; Fair KL; Steinbrueck T; Xynos FP; Donis-Keller H
    Cancer Res; 1996 Feb; 56(3):606-11. PubMed ID: 8564979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for loss of heterozygosity (LOH) at chromosomes 9p and 17p in oral granular cell tumors: a pilot study.
    Gomes CC; Fonseca-Silva T; Gomez RS
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Feb; 115(2):249-53. PubMed ID: 23312918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple target sites of allelic imbalance on chromosome 17 in Barrett's oesophageal cancer.
    Dunn J; Garde J; Dolan K; Gosney JR; Sutton R; Meltzer SJ; Field JK
    Oncogene; 1999 Jan; 18(4):987-93. PubMed ID: 10023674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma.
    Grebe SK; McIver B; Hay ID; Wu PS; Maciel LM; Drabkin HA; Goellner JR; Grant CS; Jenkins RB; Eberhardt NL
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3684-91. PubMed ID: 9360526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No preferential loss of one parental allele of chromosome 17p13.3 in childhood medulloblastoma.
    Scheurlen WG; Krauss J; Kühl J
    Int J Cancer; 1995 Nov; 63(3):372-4. PubMed ID: 7591234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor suppressor genes and medulloblastoma.
    Cogen PH; McDonald JD
    J Neurooncol; 1996 Jul; 29(1):103-12. PubMed ID: 8817421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
    Cornelis RS; van Vliet M; Vos CB; Cleton-Jansen AM; van de Vijver MJ; Peterse JL; Khan PM; Børresen AL; Cornelisse CJ; Devilee P
    Cancer Res; 1994 Aug; 54(15):4200-6. PubMed ID: 8033152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion mapping of the medulloblastoma locus on chromosome 17p.
    Cogen PH; Daneshvar L; Metzger AK; Edwards MS
    Genomics; 1990 Oct; 8(2):279-85. PubMed ID: 1979050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.